BioInfra Co.,Ltd. Logo

BioInfra Co.,Ltd.

Develops multi-biomarker blood tests for early cancer screening and gene treatments.

199730 | KO

Overview

Corporate Details

ISIN(s):
KR7199730003
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시

Description

BioInfra Co., Ltd. is a biotechnology and healthcare company specializing in innovative solutions for disease prevention and early detection, with a primary focus on oncology. The company's core technology is a proprietary multi-biomarker blood test for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This in vitro diagnostic tool analyzes a small blood sample to assess cancer risk, aiming to improve patient outcomes through early intervention. Beyond diagnostics, BioInfra also engages in pharmaceutical research and development, offering clinical research services and developing cancer gene treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-30 00:00
임시주주총회결과
Korean HTML 5.1 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean HTML 763.0 KB
2025-06-05 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 83.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 754.8 KB
2025-03-25 00:00
정기주주총회결과
Korean HTML 30.2 KB
2025-03-14 00:00
감사보고서제출
Korean HTML 18.1 KB
2025-03-14 00:00
[기재정정]주주총회소집공고
Korean HTML 103.0 KB
2025-03-14 00:00
사업보고서 (2024.12)
Korean HTML 933.5 KB
2025-03-10 00:00
현금ㆍ현물배당결정
Korean HTML 8.3 KB
2025-03-10 00:00
주주총회소집결의
Korean HTML 16.5 KB
2025-03-10 00:00
주주총회소집공고
Korean HTML 100.1 KB
2025-02-06 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 11.0 KB
2024-12-10 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2024-12-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.3 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIOTECH Logo
A biotechnology group offering preclinical services, intein development, and licensing.
Spain
BST
Biovica International B Logo
Develops blood-based biomarker assays for cancer therapy monitoring.
Sweden
BIOVIC
Bonus BioGroup Ltd. Logo
A clinical-stage biotech firm developing cell therapy and tissue engineering products.
Israel
BONS
BRAIN Biotech AG Logo
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
Germany
BNN
BriaCell Therapeutics Corp. Logo
Clinical-stage immuno-oncology company developing cellular immunotherapies for cancer.
United States of America
BCTX
BSF ENTERPRISE PLC Logo
Develops cell-based solutions for cultivated meat, leather, and corneal repair.
United Kingdom
BSFA
BullFrog AI Holdings, Inc. Logo
A technology company applying AI and machine learning to drug development.
United States of America
BFRG
Burning Rock Biotech Ltd Logo
A global diagnostics company specializing in precision oncology using NGS technology.
United States of America
BNR
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for B cell-mediated autoimmune diseases.
United States of America
CABA
CAMBRIDGE COGNITION HOLDINGS PLC Logo
Develops digital solutions and a platform for CNS clinical trials to assess brain health.
United Kingdom
COG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.